Leukotrienes in Disease Implications for Drug Development
- 1 July 1985
- journal article
- Published by Springer Nature in Drugs
- Vol. 30 (1) , 1-5
- https://doi.org/10.2165/00003495-198530010-00001
Abstract
No abstract availableKeywords
This publication has 36 references indexed in Scilit:
- Leukotriene B4‐like material in scale of psoriatic skin lesionsBritish Journal of Pharmacology, 1984
- Leukotrienes: Mediators of Immediate Hypersensitivity Reactions and InflammationScience, 1983
- Leukotriene B4 in synovial fluidJournal of Pharmacy and Pharmacology, 1982
- Structure, function, and metabolism of leukotriene constituents of SRS-A.1982
- Species difference in increased vascular permeability by synthetic leukotriene C4 and D4Prostaglandins, 1981
- Control of vascular permeability by polymorphonuclear leukocytes in inflammationNature, 1981
- A new approach to anti-inflammatory drugsBiochemical Pharmacology, 1979
- Arachidonic acid metabolism in polymorphonuclear leukocytesProceedings of the National Academy of Sciences, 1979
- Transformation of arachidonic acid and homo-gamma-linolenic acid by rabbit polymorphonuclear leukocytes. Monohydroxy acids from novel lipoxygenasesJournal of Biological Chemistry, 1976
- Liberation of histamine and formation of lysocithin‐like substances by cobra venomThe Journal of Physiology, 1938